News25/Ratings0
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by PowerUp Acquisition Corp.SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell C8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
- NEWSAspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase AgreementNEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (NASDAQ:ASBP)(NASDAQ:ASBPW), today announced that it entered into a definitive Securities Purchase Agreement (the "Agreement") on February 19, 2025, pursuant to which the Company issued to the Buyers a senior secured convertible debenture (the "Debenture"). The Debenture is only convertible in the event of a default or at the Company's discretion. The closing of the transaction is expected to occur on February 20, 2025 (the "Closing Date"). The transaction will result in gross proceeds to th
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)
- SECSEC Form 25-NSE filed by PowerUp Acquisition Corp.25-NSE - PowerUp Acquisition Corp. (0001847345) (Subject)
- NEWSAspire Biopharma Holdings, Inc., Announces Public Listing on NasdaqNEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (NASDAQ:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition Corp. stockholders on January 31, 2025, and it closed on February 17, 2025. Beginning on February 20, 2025, Aspire Biopharma shares of common stock and warrants will begin to trade on the Nasdaq G
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 425 filed by PowerUp Acquisition Corp.425 - PowerUp Acquisition Corp. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 10-Q filed by PowerUp Acquisition Corp.10-Q - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECAmendment: SEC Form 10-Q/A filed by PowerUp Acquisition Corp.10-Q/A - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECAmendment: SEC Form 10-Q/A filed by PowerUp Acquisition Corp.10-Q/A - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 425 filed by PowerUp Acquisition Corp.425 - PowerUp Acquisition Corp. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 425 filed by PowerUp Acquisition Corp.425 - PowerUp Acquisition Corp. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 425 filed by PowerUp Acquisition Corp.425 - PowerUp Acquisition Corp. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- PRAspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and SupplementsHighlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing a pipeline of products utilizing its novel delivery mechanisms to enhance the efficacy of "do no harm" FDA approved drugs, nutraceuticals and supplements.Innovative Drug Delivery Technology: Aspire's patented and patent-pending delivery system includes components specifically formulated to allow rapid sublingual absorption of drugs directly into the blood stream, thus on first pass, avoiding the gastrointestinal tract and liver, mitigating unwanted toxicity of this critical organ.Growth and
- SECSEC Form 425 filed by PowerUp Acquisition Corp.425 - PowerUp Acquisition Corp. (0001847345) (Subject)
- SECPowerUp Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form 10-Q filed by PowerUp Acquisition Corp.10-Q - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form NT 10-Q filed by PowerUp Acquisition Corp.NT 10-Q - PowerUp Acquisition Corp. (0001847345) (Filer)
- SECSEC Form RW filed by PowerUp Acquisition Corp.RW - PowerUp Acquisition Corp. (0001847345) (Filer)
PWUP FAQ
6 questionsWhat does PowerUp Acquisition Corp. do?
PowerUp Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business within the interactive media, digital media, sports, entertainment, and/or leisure areas. The company was incorporated in 2021 and is based in New York, New York.Where does PWUP stock trade?
PowerUp Acquisition Corp. (PWUP) is listed on NASDAQ.What sector and industry is PWUP in?
PowerUp Acquisition Corp. operates in the Finance sector, Blank Checks industry.When did PowerUp Acquisition Corp. go public?
PowerUp Acquisition Corp. (PWUP) completed its IPO in 2022.What companies are similar to PWUP?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare PWUP side-by-side with any of them on Quantisnow.How can I track PWUP on Quantisnow?
Quantisnow aggregates PowerUp Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PWUP to receive live email and push alerts on every new disclosure.